Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection
JCI Insight · 2024
DOI: 10.1172/jci.insight.173526 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Maureen Kleinhenz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Microbial Pathogenesis, Abigail Wexner Research Institute. Hauptthemen laut MEDLINE: Bacterial Toxins, Staphylococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIAID, Nationwide Children’s Hospital.
Abstract (Originalsprache)
BACKGROUNDT cell responses are impaired in Staphylococcus aureus-infected children, highlighting a potential mechanism of immune evasion. This study tested the hypotheses that toxin-specific antibodies protect immune cells from bacterial killing and are associated with improved T cell function following infection.METHODSS. aureus-infected and healthy children (N = 33 each) were prospectively enrolled. During acute infection and convalescence, we quantified toxin-specific IgG levels by ELISA, antibody function using a cell killing assay, and functional T cell responses by ELISPOT.RESULTSThere were no differences in toxin-specific IgG levels or ability to neutralize toxin-mediated immune cell killing between healthy and acutely infected children, but antibody levels and function increased following infection. Similarly, T cell function, which was impaired during acute infection, improved following infection. However, the response to infection was highly variable; up to half of children did not have improved antibody or T cell function. Serum from children with higher α-hemolysin-specific IgG levels more strongly protected immune cells against toxin-mediated killing. Importantly, children whose serum more strongly protected against toxin-mediated killing also had stronger immune responses to infection, characterized by more elicited antibodies and greater improvement in T cell function following infection.CONCLUSIONThis study demonstrates that, despite T cell impairment during acute infection, S. aureus elicits toxin-neutralizing antibodies. Individual antibody responses and T cell recovery are variable. These findings also suggest that toxin-neutralizing antibodies protect antigen-presenting cells and T cells, thereby promoting immune recovery. Finally, failure to elicit toxin-neutralizing antibodies may identify children at risk for prolonged T cell suppression.FUNDINGNIH National Institute of Allergy and Infectious Diseases R01AI125489 and Nationwide Children's Hospital.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Microbial Pathogenesis, Abigail Wexner Research Institute.
- Division of Critical Care Medicine; and.
- Biostatistics Resource, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Förderung
- NIAID NIH HHS
- NIAID
- Nationwide Children’s Hospital
Zitieren
APA
Kleinhenz, M., Li, Z., Chidella, U., Picard, W., Wolfe, A., Popelka, J., Alexander, R., & Montgomery, C. P. (2024). Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection. JCI Insight. https://doi.org/10.1172/jci.insight.173526
Vancouver
Kleinhenz M, Li Z, Chidella U, Picard W, Wolfe A, Popelka J, et al. Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection. JCI Insight. 2024. doi:10.1172/jci.insight.173526
BibTeX
@article{Kleinhenz2024,
author = {Kleinhenz, Maureen and Li, Zhaotao and Chidella, Usha and Picard, Walissa and Wolfe, Amber and Popelka, Jill and Alexander, Robin and Montgomery, Christopher P},
title = {Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection},
journal = {JCI Insight},
year = {2024},
doi = {10.1172/jci.insight.173526}
}
EUVIMED